Carbohydrate Metabolism, Inborn Errors - 23 Studies Found
Recruiting |
: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS : Glut1 Deficiency Syndrome : 2013-12-03 : Drug: GLUT1 DS |
Completed |
: Carbohydrate Intolerance Questionnaire Study : Carbohydrate Intolerance : 2017-04-25 : Dietary Supplement: TRUTOL Glucose Tolerance Beverage A caffeine-free, non-carbonated, glucose tolerance |
Completed |
: Measuring the Glycemic Index of Pulse Based Breads : Carbohydrate Intolerance : 2017-01-06 : Other: Bread |
Active, not recruiting |
: A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency : Genetic Sucrase-Isomaltase Deficiency : 2016-05-18 :
|
Enrolling by invitation |
: Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS : Glucose Transporter Type 1 Deficiency Syndrome : 2015-11-03 : Drug: UX007 UX007 is a liquid intended for oral (PO) administration. |
Recruiting |
: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome : Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) : 2014-01-13 : Drug: Triheptanoin Schedule A: Subjects previously treated |
Not yet recruiting |
: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) :
: 2013-12-12 : Drug: Triheptanoin Triheptanoin (C7 oil) is a 7-carbon medium chain triglyceride. |
Not yet recruiting |
: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) :
: 2013-12-11 : Drug: Triheptanoin Triheptanoin is a 7-carbon medium chain triglyceride |
Available |
: Post Study Continuation of C7 for G1D :
: 2013-12-11 : Drug: Triheptanoin Other Names:
|
Recruiting |
: The Glucose Transporter Type I Deficiency (G1D) Registry :
|